If you haven't consented to one of the experimental jabs, you're being accused of being a viral factory for the more virulent variants. Fortunately for you, that's the complete opposite of the truth. Here's what they're not telling you about COVID mutations.
I immediately went to work (this was back in March, 2020) to see if there was any way to contain COVID-19. And like many of us, that road led me to masks. It looked like various countries that had strong mask-wearing mandates had successfully managed to dodge the pandemic. And so I wrote this piece — “How We Know Masks Work.” It is still up on my blog, as I have a policy to leave up the things I’m wrong about, as well as the subjects I nail.
A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1) antigen-binding showed significant levels for immunoglobulin (Ig) G, while nucleocapsid IgG/IgM was not elicited. Acute bronchopneumonia and tubular failure were assigned as the cause of death at autopsy; however, we did not observe any characteristic morphological features of COVID-19. Postmortem molecular mapping by real-time polymerase chain reaction revealed relevant SARS-CoV-2 cycle threshold values in all organs examined (oropharynx, olfactory mucosa, trachea, lungs, heart, kidney and cerebrum) except for the liver and olfactory bulb. These results might suggest that the first vaccination induces immunogenicity but not sterile immunity.
In the next 10 to 15 years, we are likely to see spikes in prion diseases, autoimmune diseases, neurodegenerative diseases at younger ages, and blood disorders such as blood clots, hemorrhaging, stroke and heart failure...
The inexperienced members of the Bar are another matter.. Will this process, in the hands of the young lawyer, be encouraged to the advantage of the client if the sword of Rule 57.07 hangs over counsel's head as a backdrop against which the strategy of presenting the client's case is developed?
In this interview, Stephanie Seneff, Ph.D., and Judy Mikovits, Ph.D., a dream-team in terms of deep insights into the scientific details, explain the problems they see with gene-based COVID-19 vaccines. There is a load of highly useful technical information that you can use to defend your opposition to these dangerous vaccines.
SARS-CoV-2 proteins were measured in longitudinal plasma samples collected from 13 participants who received two doses of mRNA-1273 vaccine. 11 of 13 participants showed detectable levels of SARS-CoV-2 protein as early as day one after first vaccine injection. Clearance of detectable SARS-CoV-2 protein correlated with production of IgG and IgA.
The lipid nanoparticles can potentially fuse with brain cells, resulting in delayed neuro-degenerative disease. And the mRNA-induced spike protein can bind to brain tissue 10 to 20 times stronger than the spike proteins that are (naturally) part of the original virus.”
If true, we are in big trouble because spike proteins are exactly what the COVID vaccines are instructing the body to manufacture in great numbers. For SARS-CoV-2, the vaccines produced by Pfizer/BioNTech and Moderna give instructions to our cells to make our own version of the spike protein, which happens shortly following immunization.